# CYCLOPHOSPHAMIDE
> **NDA217651** · New Drug Application · Sponsor: BAXTER HLTHCARE CORP · Approved 2023-06-27
## Drug
- **FDA Application Number:** NDA217651
- **Application type:** New Drug Application
- **Brand name:** CYCLOPHOSPHAMIDE
- **Generic name:** CYCLOPHOSPHAMIDE INJECTION, SOLUTION
- **Active ingredients:** CYCLOPHOSPHAMIDE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** BAXTER HLTHCARE CORP
- **Manufacturer:** Baxter Healthcare Company
- **First approval:** 2023-06-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217651)
---
*MORVS · CC0 1.0*